You have 9 free searches left this month | for more free features.

Condition

Fibrosis (1)

Hepatic Cirrhosis (1)

Hepatic Impairment (1)

Liver Fibrosis (1)

Nonalcoholic Steatohepatitis (NASH) (1)

Overall Status

Completed (3)

Recruiting (1)

Sign in for free

Phase

phase 1 (2)

phase 2 (2)

Sponsor

Bristol-Myers Squibb (4)

Collaborator

Intervention

bms-986263 (4)

placebo (3)

diphenhydramine (1)

famotidine (1)

Study Documents

Intervention Type

drug (4)

other (3)

Funder Type

Industry (4)

Study Type

Interventional (4)

bms-986263

Showing 1 - 4 of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Hepatic Cirrhosis, Liver Fibrosis Trial in San Antonio (BMS-986263, Placebo)

Completed

Has Results

Hepatic Cirrhosis
Liver Fibrosis

BMS-986263
Placebo

San Antonio, Texas

The Texas Liver Institute

Feb 3, 2022

Hepatic Impairment Trial in San Antonio (BMS-986263)

Completed

Hepatic Impairment

BMS-986263

San Antonio, Texas

The Texas Liver Institute

Oct 29, 2021

Nonalcoholic Steatohepatitis (NASH) Trial in Worldwide (BMS-986263, Placebo)

Recruiting

Nonalcoholic Steatohepatitis (NASH)

BMS-986263
Placebo

Phoenix, Arizona
+113 more

Aug 22, 2022

Fibrosis Trial in Cypress (BMS-986263, Placebo, Diphenhydramine)

Completed

Fibrosis

BMS-986263
+3 more

Cypress, California

Wcct Global, Llc

Jan 10, 2018